MAY 27, 2016 02:37 PM PDT

One Man's Poison is Another Man's Cure

WRITTEN BY: Xuan Pham
In the wild, survival of the fittest for some plants and animals mean sporting lethal venoms and toxins to kill whatever bothers it. But ironically enough, the chemical properties that make these natural toxins so deadly are also what make it so valuable as medical cures. The catch, of course, is to extract the curative properties without the dangerous lethal side-effects. Now a team from the Scripps Research Institute say they have found a way to screen more toxins for therapeutic properties faster and more efficiently. Their system, they say, could reveal more drugs currently hiding inside of snake venom, frog poisons, and the likes.   
How scientists are harnessing nature's toxins to make new drugs
Nature’s own toxins are exquisitely efficient at killing. Some of these toxic concoctions of proteins and peptides target the nervous system, causing death by paralysis. Some dissolve cells and tissues, causing death from the inside out. Some coagulate blood into the consistency of gelatin, turning the victim into a macabre human Jell-o mold.??
 
But where’s the medicinal value of these compounds? As it turns out, some of the most active components of toxins affect the same enzymes and pathways in certain diseases. Deriving the key active ingredients from the toxins could yield huge therapeutic potentials. Aside from yielding the key chemical compound, toxins also lead scientists to better understand how certain diseases work, what pathways are affected, and what proteins may be curative. ??
 
 
So far, toxicologists are hard at work screening natural toxins for medicinal values. Of the possible 20 million toxins in nature, less than a 1,000 have been analyzed. And of that, only about a dozen have made it as a marketable drug. The process is so lengthy because it’s highly difficult to obtain sufficient quantities of the poisons or venoms naturally. In addition, once isolated, the compound has to be purified and tested in a multitude of lab conditions to see how cells respond.
 
Recognizing the vast potential of drugs that are yet undiscovered in natural toxins, the team at Scripps set to find a new way to screen for these drugs in a more efficient manner.
 
They began by assembling a list of 589 known venoms (using an animal toxin database). From this, they synthesized gene versions for each of the venoms, and inserted the gene into viruses that deliver the genes into cells. The next step is to test whether the genes have a biological effect by exposing the virus to cultured cells that have a reporter, such as a fluorescent signal, attached. When a biological target is affected by the right gene from the venom, the cells light up and alerts researchers to hone in on a particular venom.
 
As a proof-of-concept, the team screened for venoms that block a potassium ion channel known as Kv1.3. This channel, in particular, is involved in many biological processes, including inflammation and disease.
 
Using their screening technique, the team narrowed down the daunting list of 589 candidate venoms to just 27 that most likely blocked Kv1.3. Of this 27, 25 venoms have already been validated as targeting the potassium channel, indicating that the technique is effective. Of the 2 venoms that are previously unknown, one had been suspected to be involved in Kv1.3 block, and the other was verified with actual venom to be a potent Kv1.3 blocker.
 
The team hopes this method will be effective for drug discovery not only with natural toxins, but also in identifying analog versions of these compounds.

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 21, 2018
Cardiology
APR 21, 2018
Scientists Recommend Exercise After A Heart Attack
Doctors recommend regular physical activity to reduce the risk of a heart attack, but the same advice applies even after a person has a heart attack. A new...
APR 24, 2018
Cancer
APR 24, 2018
CAR-T Cell Therapy 101
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a useful tool for cancer treatments in a small number of cancers thus far. This area of treatment research is expanding rapidl...
JUN 12, 2018
Immunology
JUN 12, 2018
Auto-antibody Detection for Rheumatoid Arthritis Patients
No case of rheumatoid arthritis (RA), an autoimmune disease, is the same. Now, researchers want RA diagnostic approaches to match its pathological diversit...
AUG 08, 2018
Microbiology
AUG 08, 2018
Use of Probiotics Linked to Severe Bloating, Brain Fog
Gut bacteria can have a powerful effect on brain function....
AUG 22, 2018
Clinical & Molecular DX
AUG 22, 2018
New Clinical Assay Useful For Urothelial Cancer
U.S. Food and Drug Administration (FDA) has now approved a pharmDx assay called ‘Dako PD-L1 IHC 22C3’ by Agilent Technologies Inc. for use in u...
SEP 29, 2018
Microbiology
SEP 29, 2018
In a First, Rat Variation of Hepatitis E Found in a Person
It was found in a 56-year-old Hong Kong man....
Loading Comments...